These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 15923791

  • 1. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
    Keene KS, Harman EM, Knauf DG, McCarley D, Zlotecki RA.
    Am J Clin Oncol; 2005 Jun; 28(3):217-22. PubMed ID: 15923791
    [Abstract] [Full Text] [Related]

  • 2. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
    Choy H, Devore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH.
    Int J Radiat Oncol Biol Phys; 2000 Jul 01; 47(4):931-7. PubMed ID: 10863062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M, Kovac V, Smrdel U, Strojan P.
    J Thorac Oncol; 2006 Sep 01; 1(7):662-6. PubMed ID: 17409933
    [Abstract] [Full Text] [Related]

  • 6. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, Lee JS, Lawton C.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):469-78. PubMed ID: 9806503
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients.
    Jeremić B, Miličić B, Milisavljevic S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1157-63. PubMed ID: 21640518
    [Abstract] [Full Text] [Related]

  • 9. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
    Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J.
    J Clin Oncol; 2001 Jan 15; 19(2):442-7. PubMed ID: 11208837
    [Abstract] [Full Text] [Related]

  • 10. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study.
    Jeremic B, Milicic B, Acimovic L, Milisavljevic S.
    J Clin Oncol; 2005 Feb 20; 23(6):1144-51. PubMed ID: 15718310
    [Abstract] [Full Text] [Related]

  • 11. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H.
    Lancet Oncol; 2015 Feb 20; 16(2):187-99. PubMed ID: 25601342
    [Abstract] [Full Text] [Related]

  • 12. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B, Milicić B, Acimović L, Milisavljević S.
    J Clin Oncol; 2005 Oct 01; 23(28):6873-80. PubMed ID: 16192579
    [Abstract] [Full Text] [Related]

  • 13. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3760-7. PubMed ID: 15837967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
    Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R.
    J Clin Oncol; 2005 Apr 01; 23(10):2145-54. PubMed ID: 15800308
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.
    Lung Cancer; 2011 Feb 01; 71(2):166-72. PubMed ID: 20541833
    [Abstract] [Full Text] [Related]

  • 19. Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer.
    Adelstein DJ, Rice TW, Rybicki LA, Greskovich JF, Ciezki JP, Carroll MA, DeCamp MM.
    Lung Cancer; 2002 May 01; 36(2):167-74. PubMed ID: 11955651
    [Abstract] [Full Text] [Related]

  • 20. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):548-57. PubMed ID: 12062596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.